NEW YORK (GenomeWeb) – OvaGene Oncology and Etta Healthcare said yesterday that they have entered into a worldwide, exclusive alliance to commercialize multiplexed diagnostic tests to monitor gynecologic cancer and pre-cancerous conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.